Association of Remdesivir Treatment With Mortality Among Hospitalized Adults With COVID-19 in the United States

IMPORTANCE: SARS-CoV-2, which causes COVID-19, poses considerable morbidity and mortality risks. Studies using data collected during routine clinical practice can supplement randomized clinical trials to provide needed evidence, especially during a global pandemic, and can yield markedly larger samp...

Descripción completa

Detalles Bibliográficos
Autores principales: Chokkalingam, Anand P., Hayden, Jennifer, Goldman, Jason D., Li, Hu, Asubonteng, Julius, Mozaffari, Essy, Bush, Christopher, Wang, Jocelyn R., Kong, Amanda, Osinusi, Anu O., Gottlieb, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716380/
https://www.ncbi.nlm.nih.gov/pubmed/36454570
http://dx.doi.org/10.1001/jamanetworkopen.2022.44505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716380/
https://www.ncbi.nlm.nih.gov/pubmed/36454570
http://dx.doi.org/10.1001/jamanetworkopen.2022.44505

Ejemplares similares